Over-the-Counter Pharmaceutical Sales for Syndromic Surveillance Analysis

A research analysis by Steven F. Magruder of Johns Hopkins University Applied Physics Laboratory correlates over-the-counter pharmaceutical sales counts with physician encounter counts for public health surveillance. The study measures timeliness and illustrates a two-stage clustering method that produced 16 product supergroups. The dataset likely contains sales and clinical encounter data, though its specific size and format are not detailed.

Use Cases

• Correlating pharmaceutical sales with clinical illness measures based on the timeliness analysis described.
• Clustering OTC products into surveillance groups based on the two-stage method using sales histories.
• Analyzing the lead time of nonseasonal health fluctuations after seasonal correction as discussed in the results.
• Building syndromic surveillance models using aggregated product supergroups formed by the described clustering algorithm.

Strengths

• Analysis correlates OTC sales with clinical measures of community illness, providing a methodological foundation.
• Clustering approach produced 16 meaningful supergroups of products with similar sales histories.
• Research addresses fundamental uncertainties in OTC data timeliness and aggregation for surveillance.

Limitations

• Row count, file formats, and sample data are unknown, limiting suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• License is closed, restricting access and reuse.

Provenance

Source

Johns Hopkins University Applied Physics Laboratory

Collection Method

Timeliness measurements via correlation of pharmaceutical sales counts with physician encounter counts, with seasonal adjustment. Product aggregation via a two-stage qualitative and algorithmic clustering process.